Member Info for Cashintime

Thanks NBucky1 for organising this. Looking forward to some pressing blunt questioning. I think it is high time that we are given more information on the structure of the potential deal that we have been led to believe is in the making this year.

Nice move up now. 13p target short term I think. Investor meeting next Wednesday night with Cathal Friel should be interesting.

Looking good here alright. We need concrete news to maintain the upward projection though. They are keeping their cards close to the chest with an obvious Polb 001 deal in the making.

Well into the 2nd quarter now so can't be far away. Results and news together would be nice .

Looking forward to the RNS tomorrow morning. It better not contain anything pessimistic to hold the lid on. I would like to see it blown clean off. We are talking about billions worth of gas here.

It was always coiled to blow once everything falls into place. It has been a long drawn out saga and we will eventually get a serious re rate. It's one of a few of my AIM remaining companies in my portfolio that I have hope for

I think you are right Spuddy , as we are told we have at least 2 interested and 1 wishing totrial with Car T by years end so a deal is imminent (that favourite word).

With about £10m approx in the kitty we would like to have solid news with the results.

Just go Sanderscam, you have creamed enough off this company and disintegrated all shareholders stakes here.

You are indeed a disgrace of a CEO. The whole investment community sees you for what you are you miserable man. Karmas coming for you.

We will enter the Nasdaq this year through a reverse into an already listed company. We may be waiting for a deal to be signed for Polb 001 firstly so we bring more to the table. Hopefully it will be a company which has revenue generating products in toe already and finds our package a good fit with their own. We already have a Nasdaq listed company carrying out trials in a few months on our oral encapsulation Ano Bio collaborative project. It may be a license that they want in their stable and enough to make them ambitious to join forces with our company and it's very impressive team. This year will be our pivot to success.

This report once more this year is sickening to read.

Sanderscam giving himself once more a pay rise when he has raped this company of all value while feathering his own nest is stomach turning. He has failed miserably at everything he has ever done here at the helm. He cares nothing of the shareholders whom he has diluted to oblivion and even has the neck to state that the supportive long-term shareholders here will get rewarded by this Hydrogen storage fantasy and Lovely gas. He has no shame and should be forensically investigated by the relevant authorities to ensure that there is nothing underhand in the dealing of the past years which many long-term suffering shareholders will be aware of.

It is nearly over here as the only finance he can get is dodgy forward sold death spiral financing which at this stage will put us into liquidation. I don't want to see him profiting any more to the extent of. grand a day for being one of the world's most useless CEOs. He is one swarmy individual and I hope karma catches up on him. I would like to see the back of the sponger as I am sure many on here would.

As they say you wouldn't get a team of such quality joining Poolbeg unless they saw massive potential.

New products with cash generation will shortly be brought in by Dave Allmond and collectively with that our other projects moving forward and a partnership deal signed for 001 will knock the lids off this. Revenue at this stage is key. We are in execution mode at the moment with news incoming any day.

I would say that CF is actively working on a reverse into Nasdaq which could bring in revenue generating products for us. Will we suffer dilution when this happens remains to be seen.

It has been stated by JS that we have two different Pharmas interested in Polb 001 with one of them wanting to trial it later in the year in relation to Car-T treatment to combat the resulting Cytokine storm.

Surely this will result in a deal signed of some sort for exclusive partnership which is what Poolbeg Pharma want rather than in license to multiple parties. If it is an exclusive partnership the second party would if interested be under pressure to make their mind up if they want a slice of the cake.bThe structure of this deal is all guesswork to us stakeholders at the moment but it has been hinted that the preferred deal would be a single one covering all applications. We are adding different uses in order to make the partnership more valuable and more attractive for those nibbling at the hook.

Didn't realise LSE is closed until Tuesday so I guess we will wait until then for annual results, happy Easter all,enjoy.

Good end of the day backs to double digits on the ask. We could well get end of year results tomorrow if last year is anything to go by. It would be nice to get a cherry on top with the results. We shall see.

Https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://finance.yahoo.com/news/favourable-signals-poolbeg-pharma-numerous-080940812.html&ved=2ahUKEwjI0Y7c0ZSFAxWoTEEAHW03DlEQxfQBKAB6BAgFEAI&usg=AOvVaw3PkeL-B3CyIYX-4Flsliw8

No sign of the TW podcast yet from the other day.

Closed period after director share purchase is well and truly over now so there will be no questions asked if any good news on partnership deals , mergers or acquisitions were to be announced. End of year results due shortly. We will see what we have left in the kitty, probably about a £10m cushion to carry us through to first revenues.

"This encompasses cytokine storm induced in any disease indication."

This patent is broad and will give us far reaching IP protection for numerous eventually potential applications in many disease settings. IP is what big Pharma look for and we are expanding our protection for Polb 001 nicely.

At least a notice of allowance which is a precursor to formal patent grant. All the ducks getting lined up now.

Great news, American patent granted.

No flies on Dave. Great interview by him. Good to see JS confirming the interest of 2 Phrmas.